Focus of this event, organized in a hybrid format, is Indena’s celebration of its Centennial: one hundred years of botanical excellence since 1921.

Theme of the Congress is the Botanical Science applied to Human Health ranging from the history of taxanes to the scientific approach to dietary supplements & botanicals quality, that have characterized Indena’s history.

We are proud to celebrate a century of business together with many leading inspiring scientists and academics and we aim to honor this event by inviting the persons who accompanied Indena through the most significant chapters of its history, formed by nature, science and people.

The event will take place on 8th November at 5,00 pm CET in live streaming from the historical, prestigious venue “Istituto dei Ciechi” in via Vivaio 7, Milan.

Days

:

Hours

:

Minutes

:

Seconds

Conference Abstract: “From Taxanes to Phytosome™ technology: Botanical Science applied to Human Health”.

The well known scientist, science writer and Italian radio & tv anchor dr. Silvia Bencivelli will be with us to moderate our phygital summit.

Programme

INTRODUCTION	SILVIA BENCIVELLI
WELCOME	BENEDETTO DELLA BEFFA
NATURAL PRODUCTS AS ACTIVE INGREDIENTS: CHALLENGES AND OPPORTUNITIES OF OLD COMPOUNDS FOR MODERN DISEASES	PIETRO ALLEGRINI
TAXUS BACCATA L.: FROM A TREE OF DEATH TO A TREE OF LIFE	GIOVANNI APPENDINO
THE TAXANES: A SUCCESS STORY	MARCEL ROZENCWEIG
INDENA CENTENNIAL	DANIELE GIAVINI
THE JOURNEY OF ABRAXANE® AND RECENT DEVELOPMENTS OF NAB® TECHNOLOGY	PATRICK SOON-SHIONG and NEIL DESAI
ECOLOGY-DRIVEN DRUG DISCOVERY	PAUL REDDELL
INDENA CENTENNIAL (follows)	DANIELE GIAVINI
WINNERS DELLA BEFFA PRIZE	VALERIA CAVALLORO, SILVIA SCARPATO, SOFIA DRAKOPOULOU
MERIVA® CURCUMIN PHYTOSOME - AN INDENA MEDICAL BREAKTHROUGH	PARRIS KIDD
SCIENTIFIC APPROACH TO DIETARY SUPPLEMENTS & BOTANICALS QUALITY	ERNESTO MARCO MARTINELLI
FINAL GREETINGS	LUCA GIORGETTI
CENTENNIAL VIDEO	INDENA, THE GENIUS BEHIND

Speakers

BIAGIO AND BENEDETTO DELLA BEFFA	Members of the Board of Directors at Indena S.p.A.
DANIELE GIAVINI	Managing Director at Indena S.p.A.
LUCA GIORGETTI	Managing Director at Indena S.p.A.
PIETRO ALLEGRINI	Research and Development Director at Indena S.p.A. (click here to read more) His main current research interests are the extraction and purification of pharmaceutical intermediates and active ingredients as well as food supplement ingredients from botanical sources and the development of industrial processes for the synthesis of pharmaceutical products. He is co-founder of ISPROCHEM, an international school of process chemistry. He is also co-founder of the Master School in Process Development Applied to Active Pharmaceutical Ingredients of the University of Milan.
GIOVANNI APPENDINO	Full Professor of Organic Chemistry at the University of Eastern Piedmont (click here to read more) Giovanni Appendino is Full Professor of Organic Chemistry at the University of Eastern Piedmont, Novara, Italy. He is author of over 400 peer-reviewed articles and his h-index is 58 (WOS). His research activity takes inspiration from natural products to address problems in various realms of organic chemistry (phytochemistry, reaction mechanisms, new synthetic methods), interfacing them with biomedical research. He is editor-in-chief of the journal Fitoterapia, and his research has been recognized by the Phytochemical Society of Europe (Rhone-Poulenc Rorer Award in 1991, Brucker Prize in 2014) and by the Società Chimica Italiana (Quilico Medal in 2009 ,Piria medal in 2021).
ERNESTO MARCO MARTINELLI	QA & Regulatory Advisor at Indena S.p.A. (click here to read more) He has been a researcher in pharmaceutical chemistry of plant origin products. He has published several papers in the field of isolation and structure determination of organic natural substances by spectroscopic methods and development of analytical methods in the chemical and biological field, as well as in the field of chemometrics applied to plant origin substances.
MARCEL ROZENCWEIG	Chief Medical Officer at NeoTX and co-founder of the company (click here to read more) Dr. Marcel Rozencweig is currently Chief Medical Officer at NeoTX and a co-founder of the company. Dr. Rozencweig graduated from the Universite Libre de Bruxelles and trained in medical oncology at the Jules Bordet Cancer Institute in Brussels (Belgium). He has devoted most of his career to the development of new anticancer agents, both in academia and in the industry. He was a founding member of the Early Clinical Trials Group of the EORTC (First secretary and then president). As Visiting Scientist at the Cancer Therapy Evaluation Program NCI (1975-1978), he initiated the series of the NCI-EORTC Symposia on New Drugs in Cancer Therapy (1978-1981). In 1983, he joined the Bristol-Myers company (BMS) as head of clinical oncology in R&D. With his team, he pioneered the registrational approaches that led to the accelerated approval procedure for life threatening diseases (e.g, didanosine) and brought the carboplatin and paclitaxel blockbusters to the market. After close to 20 years at BMS, he switched to the biotechnology sector in various leadership positions, with a recent focus on immuno-oncology. He was President of Innate Pharma Inc from 2014 to 2017. He served as Adjunct Associate Professor of Medicine at NYU, New York, for more than 25 years.
PATRICK SOON-SHIONG	Physician, surgeon, scientist, inventor, technologist and philanthropist (click here to read more) Physician, surgeon, scientist, inventor, technologist and philanthropist, has devoted his career to understanding the fundamental biology driving lifethreatening diseases and translating these insights into medical innovations with global impact. He serves as Chairman and Chief Executive Officer of NantWorks, an ecosystem of companies with deep understandings in a wide variety of complex industries, from medical science to physics, from data to AI and from communications to mobility. Over the course of his career, he has pioneered novel therapies for both diabetes and cancer, including the revolutionary drug Abraxane, a protein nanoparticle, which has received U.S. Food and Drug Administration approval for the treatment of metastatic breast cancer, lung cancer and advanced pancreatic cancer in both the U.S. and E.U
NEIL DESAI	Founder, CEO and President at Aadi Bioscience Inc (click here to read more) Founder of Aadi, he has served as Aadi’s President, Chief Executive Officer and Chairman of Aadi’s board of directors since Aadi’s founding in October 2011. He is an inventor of the nab® technology, Abraxane® and FyarroTM. From October 2010 to October 2016, Dr. Desai served as Vice President, Strategic Platforms at Celgene Corporation (now Bristol Myers Squibb), a global biopharmaceutical company. Prior to Celgene, Dr. Desai served as Senior Vice President, Global Research and Development at Abraxis BioScience, Inc., a biotechnology company, from November 2008 until Abraxis BioScience was acquired by Celgene Corporation in October 2010 and as Vice President, Research & Development at Abraxis BioScience from March 1999 to October 2008. Dr. Desai has also previously served in positions of increasing seniority at American BioScience, Inc. and its predecessor companies. He has over 25 years of experience in novel therapeutic delivery systems with numerous issued patents, peer-reviewed publications and book chapters, and presentations at scientific meetings. He participated in FDA and EU Nanotechnology initiatives and was a member of the Steering Committee for the National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer. Dr. Desai holds a M.S and Ph.D. in Chemical Engineering from the University of Texas at Austin, and a B.S. in Chemical Engineering from the University Institute of Chemical Technology in Mumbai, India
PAUL REDDELL	Executive Director & Chief Scientific Officer at QBiotics Group
PARRIS KIDD	Chief Science Officer and Director of Quality at BrainMD (click here to read more) Chief Science Officer and Director of Quality for BrainMD of Irvine, California, the dietary supplement affiliate of the Amen Clinics national network, currently experiencing unprecedented growth. He has developed many new products, originated a world-class quality control program, and collaborates with the Amen physician community to serve their patients and the general public. Dr. Kidd continues to use his passion for science to support and advance integrative medicine.

Special Guest - Silvia Bencivelli

Scientist, science writer and Italian radio & tv anchor; Graduated in Medicine (MD) at the University of Pisa and Master in Science communication by the Sissa of Trieste, she is also member of Swim – Science Writers in Italy, Italian association member of the European Union of Science Journalists’ Associations (EUSJA) and of the World Federation of Science Journalists (WFSJ).

Sustainability

The event has been organized in compliance with the ISO 20121 standard: sustainable event management.

The event will be audited by a third party body TUV NORD ITALIA.

Learn more about Indena committment to sustainability.

Press Office

Do you want to know more about the Indena's world? Do you need materials or more information about our news and events? Get in touch with our Press Office, we'll be happy to support you

Indena press contacts
bcw-burson cohn & wolfe
Luisa Cavagnera: luisa.cavagnera@bcw-global.com

Contacts

If you have any questions or require assistance with your attendance at the event, please do not hesitate to contact us:

[Pro-Meet] Organisational Secretariat
E-mail rsvp@pro-meet.it

GET SOCIAL